Up to A$4,023,642, reflecting the issue of up to 321,891,357 fully paid ordinary shares at $0.0125 per share with 321,891,357 free attaching listed options exercisable at $0.03 and expiring 12 January 2026, with listing subject to meeting ASX Listing Rules. The Company has the right to accept overs.
The Placement is to Sophisticated and Professional Investors Only as defined in the Corporations Act 2001. SP Corporate Advisory and Ignite Equity are appointed as Joint Lead Managers. GBA Capital is appointed as Co-Manager.
Placement
- Placement to raise up to $3.0 million (with ability to accept overs), via the issue of up to 240,000,000 fully paid ordinary shares at $0.0125 per share with one (1) free attaching listed option for every one (1) share issued under the Placement, exercisable at $0.03 per share, with an expiry of 12 January 2026 (Options); and
Entitlement Offer
- The Company will also undertake a non-renounceable 1 for 10 Entitlement Offer to raise up to $1,023,642 via the issue of up to 81,891,357 fully paid ordinary shares at $0.0125 per share with one (1) free attaching listed option for every one (1) share issued under the Entitlement Offer, exercisable at $0.03 per share, with an expiry of 12 January 2026 (Options). Participants in the Placement will not participate in the Entitlement Offer.
The Placement and Entitlement Offer is not underwritten. Further details will be outlined in the Entitlement Offer Prospectus to be lodged on the ASX at the completion of the Placement in accordance with the indicative timetable below.
The Placement will occur as a two tranche placement up to A$3.0 million, via the issue of:
- Tranche 1 A$2,559,100 via the issue of 204,728,000 fully paid ordinary shares at an issue price of $0.0125) of the Placement will be under the Company’s 25% placement capacity under Listing Rules 7.1/7.1A; and
- Tranche 2 of A$440,900 via the issue 35,272,000 fully paid ordinary shares at an issue price of $0.0125 is to be subject to shareholder approval.
*Please note offer price is $0.0125 per share, representing a discount of 21.9% to the current share price of $0.016 and a discount of 9.5% to the 30-day VWAP prior to 24 October 2024 of $0.0138.